23andMe Bankruptcy Fuels DNA Privacy Fears as Millions’ Genetic Data Faces Sale
23andMe’s Chapter 11 bankruptcy filing has ignited serious privacy concerns, as the genetic data of millions of users is now a potential asset in the company’s sale. This sensitive information, used to predict disease predisposition and connect relatives, lacks robust federal protection under current U.S. law, unlike medical data held by healthcare providers. Experts warn of the potentially catastrophic consequences of data misuse by future owners, highlighting the irreplaceable nature of DNA and the limited recourse for individuals. The sale underscores the vulnerability of personal genetic information and the need for stronger data privacy regulations.
John Q. Hosedrinker